Allena Pharmaceuticals ALNA
$ 0.08
3.16%
Quarterly report 2022-Q2
added 08-15-2022
Country |
USA |
IPO year |
2017 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Dr. Louis Brenner |
Employees in the company |
32 |
Shares |
68 M |
Market Cap[1] |
$ 1.9 M |
EBITDA (LTM) |
$ -40.7 M |
P/E (LTM) |
-0.16 |
P/S (LTM) |
- |
EPS (LTM) |
-0.51 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.